Pinguecula: The Yellow Spot on the White of the Eye

A pinguecula (pronounced ping-GWEK-yoo-la; plural pingueculae) is a small, raised, yellowish or grey-white patch on the white of the eye, beside the clear cornea. It is common: in several population surveys of older adults, more than half of the people examined had one. It is not a cancer, and most never cause more than a cosmetic worry. This page sets out what the records say about what a pinguecula is, how it differs from its better-known relative the pterygium, who gets it, what it is made of, what happens when it becomes inflamed, the treatments that have been studied, and the uncommon cases in which a yellow spot on the eye turns out to be something else.

Table of Contents

  1. What a Pinguecula Is
  2. A Pinguecula Stops at the Edge of the Cornea
  3. More Than Half of Older Adults in Several Surveys Have One
  4. Risk Factors the Records Report
  5. Under the Microscope It Is Damaged Elastic Tissue
  6. Pingueculitis Is an Inflamed Pinguecula
  7. Pingueculae Are Linked to an Unstable Tear Film
  8. Treatments Described in the Records
  9. Contact Lens Studies Disagree
  10. Some Yellow or Raised Spots Turn Out to Be Something Else
  11. What Is Not Known
  12. Key Research Papers
  13. Connections
  14. Featured Videos

What a Pinguecula Is

The name comes from the Latin word pinguis, meaning fat or grease, after the spot's yellowish colour. A clinical reference summary describes a pinguecula as a benign, common degeneration of the conjunctiva (the thin clear skin that covers the white of the eye), usually present in both eyes though sometimes in one, seen as a grey, white or yellow mass on the conjunctiva over the eyeball. The same summary lists wind, dust, ultraviolet light and long hours working outdoors as the settings in which it appears, and states that it usually causes cosmetic complaints rather than symptoms [Somnath and Tripathy, 2023].

A Tokyo hospital study that graded pingueculae in 1,040 patients aged 1 to 95 found that prevalence rose sharply with age, that the average grade was higher in men than in women on both the nasal side and the temporal (ear) side of the eye, and that grades did not differ between the two sides. The authors concluded that a pinguecula is an age-dependent lesion that appears from young adulthood onward [Mimura and colleagues, 2011]. In a Sydney school study of 71 children aged 3 to 15, established pingueculae were seen on ordinary photographs in seven of 71 (10%), all of them aged 13 or older. Ultraviolet fluorescence photography showed areas of increased fluorescence in 23 of 71 (32%) and in none of the children aged 3 to 8; the authors hypothesised that these areas are precursors of sun damage [Ooi and colleagues, 2006].

The symptoms the records describe are a feeling of something in the eye and itching [Somnath and Tripathy, 2023], and, when the spot is inflamed, redness, swelling, pain, light sensitivity, discomfort and tearing [Frucht-Pery and colleagues, 1999]. Inflammation and the tear film are covered below.

Back to Table of Contents

A Pinguecula Stops at the Edge of the Cornea

A pinguecula and a pterygium both arise on the conjunctiva beside the cornea and share ultraviolet-associated exposure as a risk factor [Dibbs and colleagues, 2026]. The defining difference is where they go. On imaging with anterior segment optical coherence tomography (a scan that shows the front of the eye in cross-section), a pinguecula shows mildly thickened surface skin and findings similar to a pterygium, but it does not extend beyond the limbus, the ring where the white of the eye meets the clear cornea [Gündüz and colleagues, 2023]. An earlier anterior segment optical coherence tomography study described the same wedge-shaped mass of tissue in both, but in pingueculae it stopped at the limbal region, while in pterygia it pushed under the corneal surface [Soliman and Mohamed, 2012].

Blood supply also differs. In a study using optical coherence tomography angiography, the density of blood vessels in conjunctiva with a pinguecula (50.5%) was similar to normal conjunctiva (52.2%), while conjunctiva with a pterygium had a higher density (63.6%). The authors wrote that, unlike pinguecula, pterygium development includes the growth of new blood vessels [Zhao and colleagues, 2020].

Genetic work points the same way. A 2026 genome-wide study compared 1,483 people with pterygium against 1,768 people with pinguecula in its array-based analysis, a design meant to partly cancel out their shared sun exposure. It found gene regions linked to pterygium rather than pinguecula, near genes involved in immune signalling, tissue remodelling and scar-forming pathways, and the authors described this as consistent with the clinical observation that most pingueculae do not progress to pterygium [Dibbs and colleagues, 2026]. A gene-expression study of removed tissue found signs of genomic instability tied to inflammation in pterygium, and the same changes in pinguecula to a lesser extent; the authors described both as benign but on a pathway towards neoplastic change [Suarez and colleagues, 2021].

Telling the two apart is not always done well outside eye clinics. In 1,511 consecutive referrals to an Australian pterygium practice, general practitioners had misdiagnosed pterygium in 90 of 549 (16 per cent) and optometrists in 14 of 962 (1.4 per cent); almost exclusively, the error was calling a pinguecula a pterygium [Hirst and Smith, 2020]. The pterygium itself, including its surgery and recurrence, is covered on the Pterygium page.

Back to Table of Contents

More Than Half of Older Adults in Several Surveys Have One

Pinguecula is far more common than pterygium wherever both have been counted. Reported figures vary widely with age group, climate and how the eye was examined:

In groups chosen for their work, a survey of postmen in central Taiwan found pinguecula in 62.9% [Tang and colleagues, 1999], and a Danish study of 217 male welders found it in 57%, against 41% in a control group examined on a previous occasion [Norn and Franck, 1991].

Back to Table of Contents

Risk Factors the Records Report

Outdoor work and sunlight. Outdoor exposure is the factor that turns up most consistently. In rural Shanghai, working outdoors (daily sunlight exposure of 2 hours or more) was an independent risk factor (p = 0.001) [Le and colleagues, 2015]. In a Jordanian eye-clinic study of 241 patients, outdoor occupational activity was the only factor linked to pinguecula (odds ratio 5.16, 95% confidence interval 1.98 to 13.44) [Jammal and colleagues, 2023]. In Spain, outdoor activity carried an adjusted odds ratio of 2.07 (95% confidence interval 1.36 to 3.15) [Viso and colleagues, 2011]. Among Taiwanese postmen, each added unit of cumulative occupational sunlight (one year multiplied by one hour per day) raised the risk of pinguecula by 2.1% [Tang and colleagues, 1999]. In Chennai, people who did not wear spectacles had higher odds of pinguecula (odds ratio 1.69, 95% confidence interval 1.38 to 2.08) [Asokan and colleagues, 2012]. A 2026 French study of 77 maritime professionals and 70 people without heavy light exposure found a higher risk of conjunctival lesions (pinguecula and/or pterygium) in the exposed group, highlighted the role of light reflected from water, and found that protective solar equipment reduced the risk of eye damage in certain conditions [Sagnard and colleagues, 2026].

The ultraviolet link is weaker than for pterygium. A 2014 review of ultraviolet light and eye disease judged the evidence strong for pterygium, cortical cataract and several other conditions, but wrote that the evidence linking ultraviolet exposure to pinguecula "remained limited" [Yam and Kwok, 2014]. Laboratory findings that point to light damage are described in the microscope section below.

Age. Prevalence rose with age in Shanghai (p = 0.002), Spain (p = 0.002), Tehran (p<0.001) and the Tokyo grading study [Le and colleagues, 2015; Viso and colleagues, 2011; Fotouhi and colleagues, 2009; Mimura and colleagues, 2011]. In the Jordanian study, age was not significantly associated [Jammal and colleagues, 2023].

Sex. Most of the surveys above found more pinguecula in men. In the Tehran Geriatric Eye Study, male sex carried an odds ratio of 2.21 (95% confidence interval 1.63 to 2.99), and education level carried an odds ratio of 0.52 ( 95% confidence interval 0.35 to 0.77) [Hashemi and colleagues, 2025]. In the Blue Mountains study the odds ratio for men was 1.5 (95% confidence interval 1.3 to 1.7) [Panchapakesan and colleagues, 1998]. Not every study agrees: in rural Shanghai, sex was not associated after adjusting for age and outdoor work [Le and colleagues, 2015], and in Jordan, sex was not significantly associated either [Jammal and colleagues, 2023]. In the Chennai counts, more of the people with pinguecula were women (507) than men (368) [Asokan and colleagues, 2012].

Alcohol and smoking. The Spanish study found pinguecula associated with alcohol intake (adjusted odds ratio 3.08, 95% confidence interval 1.60 to 5.95) [Viso and colleagues, 2011], and the Shahroud study linked it with smoking [Rezvan and colleagues, 2012]. The Chennai study found no association with smoking or alcohol use [Asokan and colleagues, 2012], and the Shanghai study found none with alcohol or smoking after adjustment [Le and colleagues, 2015].

Diabetes. A Tokyo study of 160 people with type 2 diabetes and 160 controls found pinguecula on the nasal side in 55.0% against 40.0%, and diabetes was independently associated with the severity of pinguecula [Mimura and colleagues, 2012, diabetes study]. A Jordanian study found no difference (66.4% against 66.5%) [Jammal and colleagues, 2023], and the Chennai study found no association with diabetes [Asokan and colleagues, 2012].

Back to Table of Contents

Under the Microscope It Is Damaged Elastic Tissue

Despite the name, the material that the microscope studies describe in a pinguecula is abnormal connective tissue and clumped protein. Electron microscopy of three pingueculae and eight pterygia found elastic fibres being formed in a distorted way, a layer of degenerated collagen just beneath the surface skin, and masses of elastic-fibre building blocks. The authors concluded that much of both lesions is newly made, abnormal elastic tissue ("elastodysplasia") that then breaks down ("elastodystrophy"), presumed to be produced by connective-tissue cells damaged by light [Austin and colleagues, 1983]. A 1979 study of three pingueculae compared them with the sun-damaged elastic tissue of skin (actinic elastosis) and concluded that pinguecula, like that skin change, is believed to result from abnormal elastic-fibre production triggered by chronic irradiation, followed by degeneration [Ledoux-Corbusier and Danis, 1979].

A 1991 study that labelled the components found elastin, microfibrillar protein and amyloid P together in the abnormal fibres, where they never co-locate normally, and strong staining for lysozyme in the dense deposits beneath the surface skin. The authors wrote that the poorly protected conjunctiva appears to suffer more severe light-related cell damage than skin [Li and colleagues, 1991].

Two Japanese studies examined the deposits for markers of ageing proteins. Advanced glycation end products (sugar-damaged proteins) stained moderately to strongly in the deposits of all nine pinguecula specimens and weakly or not at all in conjunctiva without pinguecula [Kaji and colleagues, 2006]. Proteins containing D-beta-aspartic acid, an unusual altered form of an amino acid that builds up with age, stained strongly in all eight pinguecula specimens and not at all in the comparison tissue; the authors noted that this conversion is accelerated by ultraviolet light [Kaji and colleagues, 2009].

The surface skin over a pinguecula is also abnormal. In 12 removed pingueculae, the covering cells had lost markers of normal conjunctival cells and of mucus-making cells, gained markers of skin-type cells, and were actively dividing; the authors described pinguecula as a condition of abnormal surface-cell maturation with squamous proliferation and metaplasia [Dong and colleagues, 2009]. With a confocal microscope, small surface features called Fuchs flecks were found in 19 of 20 pingueculae (95.0%), and also in 24 of 30 (80.0%) normal-looking regions near the nose or limbus; the authors suggested these may be precursor lesions to ultraviolet-related surface disease [Ip and colleagues, 2015].

Back to Table of Contents

Pingueculitis Is an Inflamed Pinguecula

A pinguecula can become swollen, red and sore. This is called pingueculitis. In a Turkish study of 32 people with a symptomatic inflamed pinguecula in one eye, 23 of those eyes (72%) had dotted staining or a small defect on the nearby nasal cornea, against 1 fellow eye (3.1%) and none of the healthy controls. Both the affected eye and the other eye had shorter tear break-up times and lower tear production than the controls [Küçük and colleagues, 2018].

Inflammation of a pinguecula can also be imaged. In 22 people with pingueculitis (4 men and 18 women, average age 37.7), anterior segment optical coherence tomography showed a significant fall in the thickness and cross-sectional area of the lesion after treatment, and a return to a uniform conjunctival structure [Song and colleagues, 2019]. The treatment used in that study is described in the next sections.

Pingueculitis is not always what it looks like. Several records describe other conditions that were first taken for an inflamed pinguecula; these appear in the section on spots that turn out to be something else.

Back to Table of Contents

Pingueculae Are Linked to an Unstable Tear Film

Several studies have measured the tear film in people with pinguecula. In 57 people with pinguecula against 57 age-matched controls, tear production (Schirmer test) was the same (22.72 mm against 22.7 mm), but the tear film broke up faster (11.42 seconds against 15.46 seconds), and the mucus pattern on a ferning test was more often abnormal [Oguz and colleagues, 2001]. In a study of soft contact lens wearers and non-wearers, tear break-up time was lower in people with pinguecula in both groups [Dundar and Kocasarac, 2019]. After 12 pingueculae were removed, tear break-up time was significantly longer one month later, while tear production did not change [Dong and colleagues, 2009].

Removal studies in people with dry-eye symptoms report the same direction. In 30 people with a nasal pinguecula and dry-eye symptoms who had it removed and covered with a graft of their own conjunctiva held by fibrin glue, average tear break-up time went from 5.10 to 7.80 seconds, Schirmer test from 6.07 to 7.27 mm, and dry-eye symptom score from 2.80 to 0.30 points at three months [Jeong and colleagues, 2019]. A single case report described a 36-year-old man whose dry-eye signs in one eye resolved after argon laser removal of a raised pinguecula; the authors coined the term "pinguecula-related dry eye disease" [Napoli and colleagues, 2017]. These are small, uncontrolled studies.

Pinguecula also travels with other surface changes. In a Tokyo study of 1,061 patients, pinguecula was independently associated with conjunctivochalasis, a loose, folded conjunctiva (odds ratio 1.44 on the nasal side and 1.43 on the temporal side) [Mimura and colleagues, 2012, conjunctivochalasis study]. The wider condition is covered on the Dry Eye Disease page.

Back to Table of Contents

Treatments Described in the Records

Lubricating drops. The clinical reference summary describes mild symptoms such as a foreign-body feeling and itching as treated with artificial tears, and states that surgical removal is rarely undertaken, for cosmetic reasons [Somnath and Tripathy, 2023].

Short anti-inflammatory courses for pingueculitis. In the 22-person pingueculitis study, every patient was given the same two-week course of prednisolone acetate 1% drops four times a day. Dry-eye symptom scores fell from 3.27 to 1.13, the lesions shrank on imaging, and patients were followed for an average of 14.7 months; the authors wrote that the short steroid course treated the inflammation in a sustained manner [Song and colleagues, 2019]. A randomised, double-masked trial in 50 people with an inflamed pinguecula (33) or pterygium (17) compared indomethacin 0.1% drops (a non-steroidal anti-inflammatory) with dexamethasone 0.1% drops (a steroid); the trial gave each six times daily for 3 days, then four times daily for 11 days. Both groups improved by day 14 (P = .001) with no difference between them; after the drops stopped, signs came back more in the dexamethasone group (P = .023 at day 30), and the dexamethasone group reported more stinging (P = .002) [Frucht-Pery and colleagues, 1999]. An earlier placebo-controlled trial by the same group in 51 people found that indomethacin 0.1% lowered sign and symptom scores more than placebo at days 3, 7 and 14, except for signs at day 14; all patients reported mild stinging for under a minute [Frucht-Pery and colleagues, 1997]. Two case reports describe improvement after a depot steroid (betamethasone) was injected into the pinguecula [Arenas-Archila and colleagues, 2014]. The Pterygium page sets out the eye-pressure and cataract risks recorded for long-term steroid drops.

Surgical removal. In two Korean studies, surgeons removed the pinguecula and covered the bare area with a small graft of the person's own conjunctiva held with fibrin glue. In 31 eyes followed for 12 months, 29 of 31 (93.5%) rated the cosmetic result excellent or good, and a score for surrounding blood vessels fell from 2.13 to 0.09 [Jung and colleagues, 2017]. The dry-eye results of the same technique are given in the section above [Jeong and colleagues, 2019].

Argon laser. A Korean study compared argon laser photocoagulation (21 eyes) with surgical removal (23 eyes) over one year. Cosmetic results were excellent or good in 90.5% of laser-treated eyes and 78.6% of surgically treated eyes, a difference that was not significant (P = 0.15); 19 laser-treated eyes (90.5%) showed complete removal, and anatomic results did not differ significantly between the groups. Bleeding under the conjunctiva and scarring with an irregular surface were less frequent after the laser (the abstract gives 34.8% against 0% and 30.4% against 4.8%) [Ahn and colleagues, 2013].

Cosmetic eye-whitening surgery is a different operation. A Seoul review covered 1,713 people who had wide removal of conjunctiva with mitomycin C drops afterwards, mainly to reduce redness; pinguecula was the recorded diagnosis in 1.5%. The overall complication rate was 82.9%, of which 55.6% were considered severe, including regrowth of fibrous, vascular tissue (43.8%), raised eye pressure (13.1%), thinning of the sclera (4.4%), thinning with calcified plaques (6.2%), double vision (3.6%) and return of redness (28.1%). The authors wrote that the procedure has a high rate of complications and reoperations [Lee and colleagues, 2013].

Back to Table of Contents

Contact Lens Studies Disagree

Two studies of contact lens wearers reached different answers. A Tokyo study of 600 lens wearers (94 hard, 506 soft) and 579 non-wearers found the pinguecula grade on the temporal side higher in wearers (P = 0.01907), and higher in hard-lens wearers than soft-lens wearers on both sides; the authors suggested that lens use is an important risk factor [Mimura and colleagues, 2010]. A Turkish study of 233 soft-lens wearers and 230 age-matched non-wearers found pinguecula in 27.8% against 26.5%, no significant difference, and no effect of how many years lenses had been worn. In that study, people with pinguecula who did not wear lenses had higher symptom scores than those without pinguecula, while among lens wearers there was no such difference; the authors suggested lenses may dampen the irritation [Dundar and Kocasarac, 2019].

On fitting, a 1993 survey of contact lens specialists reported that many patients with pingueculae or pterygia can be successful contact lens wearers, and described the management techniques the practitioners used [Prediger and Edmondson, 1993].

Back to Table of Contents

Some Yellow or Raised Spots Turn Out to Be Something Else

The cancer that the records discuss here is ocular surface squamous neoplasia, a group of abnormal growths of the surface of the conjunctiva and cornea that, in the case series below, ranged from dysplasia to invasive squamous cell carcinoma. Sun exposure is its strongest recorded risk factor in one study below, and the records describe three kinds of overlap with pinguecula.

Pinguecula as a marker of sun exposure in people with surface cancer. In a United States veterans' case-control study of 55 people with biopsy-proven ocular surface squamous neoplasia and 55 age-matched controls, lifetime sun exposure was the strongest risk factor, and pingueculae, used as a marker of sun exposure, carried an odds ratio of 5.267 (95% confidence interval 2.104 to 13.186) [Smith and colleagues, 2019]. In a 10-year Hong Kong review of 50 eyes (24 with ocular surface squamous neoplasia), the annual incidence was 0.34 per 100,000 persons, and moderate-to-severe dysplastic lesions were more often associated with pterygia or pinguecula (p = 0.034); the authors reported that a history of pterygia and/or pinguecula was associated with the cancer in their population [Kam and colleagues, 2026].

A "pinguecula" that was cancer. In a series of six patients with suspicious conjunctival growths, the diagnosis suspected before surgery was pterygium or pinguecula in two; the final tissue diagnoses across the six were invasive squamous cell carcinoma in four, carcinoma in situ in one and dysplasia in one. The authors stressed that tissue examination is essential for a definitive diagnosis [Alharbi and colleagues, 2024].

Other look-alikes. A 2026 case report describes a 37-year-old woman with a gelatinous, cystic mass on the conjunctiva first diagnosed as recurrent pingueculitis; removal and tissue examination showed IgG4-related disease, an immune-driven inflammatory condition [Lippin and colleagues, 2026]. In a case series of eight eyes with actinic granuloma (a sun-related inflammatory nodule), one had been diagnosed clinically as episcleritis versus inflamed pinguecula, and two of the granulomas arose within a pinguecula [Magan and colleagues, 2021]. Two patients with a nodular form of scleritis had the clinical appearance of an inflamed pinguecula [Grullon and colleagues, 2025].

The imaging review cited above describes ocular surface squamous neoplasia on anterior segment optical coherence tomography as thickened, bright surface skin with an abrupt transition from normal to abnormal skin, a different picture from the mildly thickened skin of a pinguecula [Gündüz and colleagues, 2023]. The Pterygium page lists the red flags described for ocular surface squamous neoplasia, such as a gelatinous surface, white plaques, prominent feeding vessels and rapid growth. Sudden loss of vision, a severely painful red eye, or an eye injury are signs that hospitals treat as urgent.

Back to Table of Contents

What Is Not Known

Back to Table of Contents

Key Research Papers

  1. Hashemi A, Aghamirsalim M, Hashemi H, Malekifar P, Khabazkhoob M. Prevalence of pterygium and pinguecula and their risk factors: Tehran Geriatric Eye Study. Int J Ophthalmol. 2025;18(4):699-706. PubMed PMID: 40256028
  2. Sagnard M, Valero B, D'aiello A, Agard E, El Chehab H. Ocular risks related to light overexposure in maritime professionals in the Provence-Alpes-Côte d'Azur Region, France: The PHOTOPPA study. J Fr Ophtalmol. 2026;49(5):104885. PubMed PMID: 42025255
  3. Assylbek N, Norval M, McLoone P. An evaluation of skin and eye diseases associated with exposure to solar ultraviolet radiation in Central Asia. Photochem Photobiol Sci. 2026;25(1):1-14. PubMed PMID: 41524871
  4. Le Q, Xiang J, Cui X, Zhou X, Xu J. Prevalence and associated factors of pinguecula in a rural population in Shanghai, Eastern China. Ophthalmic Epidemiol. 2015;22(2):130-8. PubMed PMID: 25777313
  5. Viso E, Gude F, Rodríguez-Ares MT. Prevalence of pinguecula and pterygium in a general population in Spain. Eye (Lond). 2011;25(3):350-7. PubMed PMID: 21183945
  6. Asokan R, Venkatasubbu RS, Velumuri L, Lingam V, George R. Prevalence and associated factors for pterygium and pinguecula in a South Indian population. Ophthalmic Physiol Opt. 2012;32(1):39-44. PubMed PMID: 22112236
  7. Panchapakesan J, Hourihan F, Mitchell P. Prevalence of pterygium and pinguecula: the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1998;26 Suppl 1:S2-5. PubMed PMID: 9685008
  8. Fotouhi A, Hashemi H, Khabazkhoob M, Mohammad K. Prevalence and risk factors of pterygium and pinguecula: the Tehran Eye Study. Eye (Lond). 2009;23(5):1125-9. PubMed PMID: 18600244
  9. Rezvan F, Hashemi H, Emamian MH, Kheirkhah A, Shariati M, Khabazkhoob M, et al. The prevalence and determinants of pterygium and pinguecula in an urban population in Shahroud, Iran. Acta Med Iran. 2012;50(10):689-96. PubMed PMID: 23275285
  10. Mimura T, Usui T, Obata H, Yamagami S, Mori M, Funatsu H, et al. Severity and determinants of pinguecula in a hospital-based population. Eye Contact Lens. 2011;37(1):31-5. PubMed PMID: 21178698
  11. Tang FC, Chen SC, Lee HS, Lin WF, Chou MC, Lee MC. Relationship between pterygium/pinguecula and sunlight exposure among postmen in central Taiwan. Zhonghua Yi Xue Za Zhi (Taipei). 1999;62(8):496-502. PubMed PMID: 10462825
  12. Norn M, Franck C. Long-term changes in the outer part of the eye in welders. Prevalence of spheroid degeneration, pinguecula, pterygium, and corneal cicatrices. Acta Ophthalmol (Copenh). 1991;69(3):382-6. PubMed PMID: 1927324
  13. Jammal HM, Abu-Ameerh M, Hiasat JG, Issa S, Al Bdour M. The Relationship between Pinguecula and Diabetes Mellitus: A Comparative Cross-Sectional Study. J Ophthalmol. 2023;2023:9060495. PubMed PMID: 36895265
  14. Mimura T, Obata H, Usui T, Mori M, Yamagami S, Funatsu H, et al. Pinguecula and diabetes mellitus. Cornea. 2012;31(3):264-8. PubMed PMID: 22420025
  15. Yam JC, Kwok AK. Ultraviolet light and ocular diseases. Int Ophthalmol. 2014;34(2):383-400. PubMed PMID: 23722672
  16. Ooi JL, Sharma NS, Papalkar D, Sharma S, Oakey M, Dawes P, et al. Ultraviolet fluorescence photography to detect early sun damage in the eyes of school-aged children. Am J Ophthalmol. 2006;141(2):294-8. PubMed PMID: 16458683
  17. Austin P, Jakobiec FA, Iwamoto T. Elastodysplasia and elastodystrophy as the pathologic bases of ocular pterygia and pinguecula. Ophthalmology. 1983;90(1):96-109. PubMed PMID: 6828309
  18. Li ZY, Wallace RN, Streeten BW, Kuntz BL, Dark AJ. Elastic fiber components and protease inhibitors in pinguecula. Invest Ophthalmol Vis Sci. 1991;32(5):1573-85. PubMed PMID: 2016139
  19. Ledoux-Corbusier M, Danis P. Pinguecula and actinic elastosis. An ultrastructural study. J Cutan Pathol. 1979;6(5):404-13. PubMed PMID: 93118
  20. Kaji Y, Oshika T, Amano S, Okamoto F, Koito W, Horiuchi S. Immunohistochemical localization of advanced glycation end products in pinguecula. Graefes Arch Clin Exp Ophthalmol. 2006;244(1):104-8. PubMed PMID: 16034606
  21. Kaji Y, Oshika T, Okamoto F, Fujii N. Immunohistochemical localisation of D-beta-aspartic acid in pingueculae. Br J Ophthalmol. 2009;93(7):974-6. PubMed PMID: 19276098
  22. Dong N, Li W, Lin H, Wu H, Li C, Chen W, et al. Abnormal epithelial differentiation and tear film alteration in pinguecula. Invest Ophthalmol Vis Sci. 2009;50(6):2710-5. PubMed PMID: 19182253
  23. Suarez MF, Echenique J, López JM, Medina E, Irós M, Serra HM, et al. Transcriptome Analysis of Pterygium and Pinguecula Reveals Evidence of Genomic Instability Associated with Chronic Inflammation. Int J Mol Sci. 2021;22(21):12090. PubMed PMID: 34769520
  24. Dibbs M, Demkowicz P, Zaher HM, Paskali E, Jayaraj C, Shin D, et al. Genome-Wide Association Study of Pterygium Versus Pinguecula Identifies Loci Associated with Lesion-Type Divergence. Ophthalmol Sci. 2026;6(11):101362. PubMed PMID: 42830781
  25. Zhao F, Cai S, Huang Z, Ding P, Du C. Optical Coherence Tomography Angiography in Pinguecula and Pterygium. Cornea. 2020;39(1):99-103. PubMed PMID: 31436638
  26. Gündüz AK, Mirzayev I, Okcu Heper A, Kuzu I, Gahramanli Z, Cansiz Ersöz C, et al. Anterior segment optical coherence tomography in ocular surface tumours and simulating lesions. Eye (Lond). 2023;37(5):925-937. PubMed PMID: 36513855
  27. Soliman W, Mohamed TA. Spectral domain anterior segment optical coherence tomography assessment of pterygium and pinguecula. Acta Ophthalmol. 2012;90(5):461-5. PubMed PMID: 21040504
  28. Oguz H, Karadede S, Bitiren M, Gurler B, Cakmak M. Tear functions in patients with pinguecula. Acta Ophthalmol Scand. 2001;79(3):262-5. PubMed PMID: 11401635
  29. Küçük E, Yılmaz U, Zor KR. Corneal Epithelial Damage and Impaired Tear Functions in Patients with Inflamed Pinguecula. J Ophthalmol. 2018;2018:2474173. PubMed PMID: 30515317
  30. Song H, Rand GM, Kwon JW. Clinical Features of Pingueculitis Revealed by Anterior Segment Optical Coherence Tomography Findings. Eye Contact Lens. 2019;45(6):394-398. PubMed PMID: 31663916
  31. Frucht-Pery J, Siganos CS, Solomon A, Shvartzenberg T, Richard C, Trinquand C. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study. Am J Ophthalmol. 1999;127(2):148-52. PubMed PMID: 10030555
  32. Frucht-Pery J, Solomon A, Siganos CS, Shvartzenberg T, Richard C, Trinquand C. Treatment of inflamed pterygium and pinguecula with topical indomethacin 0.1% solution. Cornea. 1997;16(1):42-7. PubMed PMID: 8985633
  33. Ahn SJ, Shin KH, Kim MK, Wee WR, Kwon JW. One-year outcome of argon laser photocoagulation of pinguecula. Cornea. 2013;32(7):971-5. PubMed PMID: 23449487
  34. Napoli PE, Sanna R, Iovino C, Fossarello M. Resolution of pinguecula-related dry eye disease after argon laser photocoagulation. Int Med Case Rep J. 2017;10:247-250. PubMed PMID: 28769593
  35. Jeong J, Rand GM, Kwon T, Kwon JW. The Improvement of Dry Eye Symptoms after Pinguecula Excision and Conjunctival Autograft with Fibrin Glue. J Ophthalmol. 2019;2019:6438157. PubMed PMID: 31281668
  36. Jung S, Kwon JW, Hwang HS, Chuck RS. Vascular Regression After Pinguecula Excision and Conjunctival Autograft Using Fibrin Glue. Eye Contact Lens. 2017;43(3):199-202. PubMed PMID: 27058827
  37. Mimura T, Usui T, Mori M, Yamamoto H, Obata H, Yamagami S, et al. Pinguecula and contact lenses. Eye (Lond). 2010;24(11):1685-91. PubMed PMID: 20829887
  38. Dundar H, Kocasarac C. Relationship Between Contact Lens and Pinguecula. Eye Contact Lens. 2019;45(6):390-393. PubMed PMID: 30801268
  39. Prediger JP, Edmondson LL. Management of contact lens patients with pingueculae or pterygia. Optom Vis Sci. 1993;70(1):9-14. PubMed PMID: 8430014
  40. Smith LM, Lamba S, Karp CL, Galor A. Epidemiology of ocular surface squamous neoplasia in veterans: a retrospective case-control study. Eye Vis (Lond). 2019;6:14. PubMed PMID: 31131286
  41. Kam KW, Chau YCC, Young AL. Epidemiology of ocular surface squamous neoplasia and squamous papillomas in Hong Kong Chinese: A 10-year review. Eur J Ophthalmol. 2026 (online ahead of print):11206721261476878. PubMed PMID: 42565779
  42. Alharbi I, Alfawaz AM, Otaif W, Al-Dahmash SA, Alkatan HM. Variable presentations of six conjunctival/limbal ocular surface squamous neoplasia (OSSN) cases: How good is our clinical judgment evidenced by the correlation to the histopathological findings and diagnosis?. Int J Surg Case Rep. 2024;116:109359. PubMed PMID: 38330700
  43. Lippin N, Karp CL, Friehmann A. Case Report: A Peculiar Pinguecula? A Surprising IgG4-Related Conjunctival Lesion. Case Rep Ophthalmol. 2026;17(1):539-544. PubMed PMID: 42338636
  44. Magan T, Rapuano CJ, Ayres BD, Skeens HM, Goyal V, Heersink S, et al. Actinic Granuloma of the Conjunctiva: Case Series and Review of the Literature. Am J Ophthalmol. 2021;229:120-126. PubMed PMID: 33895150
  45. Hirst LW, Smith J. Accuracy of diagnosis of pterygium by optometrists and general practitioners in Australia. Clin Exp Optom. 2020;103(2):197-200. PubMed PMID: 31060100
  46. Mimura T, Mori M, Obata H, Usui T, Yamagami S, Funatsu H, et al. Conjunctivochalasis: associations with pinguecula in a hospital-based study. Acta Ophthalmol. 2012;90(8):773-82. PubMed PMID: 21518307
  47. Pham TQ, Wang JJ, Rochtchina E, Mitchell P. Pterygium, pinguecula, and 5-year incidence of cataract. Am J Ophthalmol. 2005;139(6):1126-8. PubMed PMID: 15953456
  48. Grullon JR, Mueller C, Iacob CE, Swan R. Use of cyclosporine A 0.05% ophthalmic emulsion for a distinctive intrapalpebral phenotype of anterior scleritis. BMJ Case Rep. 2025;18(2):e264327. PubMed PMID: 39979032
  49. Somnath A, Tripathy K. Pinguecula. In: StatPearls [Internet]. 2023. PubMed PMID: 32644391
  50. Ip MH, Chui JJ, Tat L, Coroneo MT. Significance of Fuchs Flecks in Patients With Pterygium/Pinguecula: Earliest Indicator of Ultraviolet Light Damage. Cornea. 2015;34(12):1560-3. PubMed PMID: 26398157
  51. Lee S, Go J, Rhiu S, Stulting RD, Lee M, Jang S, et al. Cosmetic regional conjunctivectomy with postoperative mitomycin C application with or without bevacizumab injection. Am J Ophthalmol. 2013;156(3):616-622.e3. PubMed PMID: 23570698
  52. Arenas-Archila E, Arellano K, Muñoz-Sarmiento D. [Intra-lesional injection of betamethasone for the treatment of symptomatic pinguecula]. Arch Soc Esp Oftalmol. 2014;89(10):408-10. PubMed PMID: 24269437

PubMed Topic Searches

  1. PubMed: pinguecula prevalence
  2. PubMed: pinguecula histopathology
  3. PubMed: pingueculitis
  4. PubMed: pinguecula excision
  5. PubMed: pinguecula and contact lenses
  6. PubMed: pinguecula and ultraviolet light

Back to Table of Contents

Connections

Back to Table of Contents